NuPotential
Baton Rouge, US · 1 known investors
Find your way into NuPotential
Developing 'Epi-drugs' that modulate epigenetic targets for cancer and other diseases.
Founders & leadership
KJ
Kenneth J EilertseninFounder
Board
JP
Joan P NeuschelerBoard director
RB
Ross BarrettBoard director
CO
Charles OehlerBoard director
JF
Investors · 1
Reported raises · per SEC filings
Form D private placements$375K disclosed across 1 round · 2013
▶$375KraisedMar 2014 · 5 investors · PharmaceuticalsRule 506(b)
▶$375KraisedMar 2014 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joan P NeuschelerExecutive Officer, Director
- Ross BarrettDirector
- Kenneth J EilertsenDirector
- Charles OehlerDirector
- Joseph F LovettExecutive Officer, Director
- Offering amount
- $375K
- Amount sold
- $375K
- Minimum investment
- $25K
- First sale
- Oct 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does NuPotential do?
- Developing 'Epi-drugs' that modulate epigenetic targets for cancer and other diseases.
- Who founded NuPotential?
- NuPotential was founded by Kenneth J Eilertsen.
- Who are NuPotential's investors?
- NuPotential's investors include Louisiana Funds.
- How much funding has NuPotential raised?
- NuPotential has disclosed $375K raised across 1 round.
- Where is NuPotential headquartered?
- NuPotential is headquartered in Baton Rouge, US.